:@0.085519:0.075583:0.090751:0.075583:0.090751:0.059604:0.085519:0.059604:0.005232
 :@0.621674:0.075583:0.626906:0.075583:0.626906:0.059604:0.621674:0.059604:0.005232
Keynote Speaker Abstract :@0.719308:0.075583:0.919856:0.075583:0.919856:0.059604:0.719308:0.059604:0.010559:0.008929:0.008569:0.009497:0.009592:0.005251:0.008929:0.005308:0.010407:0.009535:0.008834:0.008531:0.008436:0.008929:0.006331:0.005232:0.010464:0.009346:0.008511:0.005289:0.006275:0.008531:0.008531:0.005502:0.005232
 :@0.884977:0.940183:0.890322:0.940183:0.890322:0.922163:0.884977:0.922163:0.005345
From Bench to Bedside to Business   Translating Science into Impact. A :@0.114738:0.138154:0.891385:0.138154:0.891385:0.116169:0.114738:0.116169:0.013094:0.008686:0.013120:0.019641:0.006521:0.014580:0.013068:0.013407:0.011816:0.013355:0.006599:0.007564:0.013042:0.006599:0.014580:0.013068:0.013537:0.011842:0.006651:0.013537:0.013120:0.006521:0.007668:0.013146:0.006417:0.014580:0.013355:0.011842:0.006651:0.013407:0.013068:0.011842:0.011842:0.006521:0.012190:0.006556:0.013042:0.008738:0.012650:0.013355:0.011842:0.006729:0.012650:0.007668:0.006729:0.013355:0.013511:0.006599:0.014398:0.011816:0.006573:0.013068:0.013407:0.011816:0.013068:0.006599:0.006651:0.013407:0.007668:0.013120:0.006417:0.007356:0.019693:0.013407:0.012650:0.011816:0.007668:0.008738:0.006521:0.014372:0.006521
–:@0.499335:0.138154:0.511203:0.138154:0.511203:0.116169:0.499335:0.116169:0.011868
Personal Experience in Spinning a Biotech Start-up in Singapore :@0.155644:0.162242:0.850829:0.162242:0.850829:0.140257:0.155644:0.140257:0.014659:0.013068:0.008686:0.011842:0.013146:0.013355:0.012650:0.006756:0.006657:0.013094:0.011685:0.013407:0.013068:0.008686:0.006729:0.013068:0.013407:0.011816:0.013068:0.006599:0.006651:0.013407:0.006521:0.014398:0.013433:0.006651:0.013407:0.013355:0.006703:0.013355:0.013511:0.006599:0.012650:0.006521:0.014580:0.006651:0.013172:0.007564:0.013068:0.011816:0.013433:0.006521:0.014398:0.007668:0.012729:0.008686:0.008037:0.008694:0.013355:0.013537:0.006573:0.006547:0.013355:0.006573:0.014398:0.006651:0.013407:0.013511:0.012650:0.013537:0.013146:0.008686:0.013117:0.006521
Too Heng Phon :@0.426501:0.204636:0.580068:0.204636:0.580068:0.184574:0.426501:0.184574:0.011901:0.011901:0.011901:0.006570:0.014639:0.011211:0.011925:0.011901:0.006570:0.012949:0.011901:0.011759:0.011869:0.006570
Yong Loo Lin School of Medicine, National University of Singapore, Singapore :@0.204437:0.234613:0.801050:0.234613:0.801050:0.216593:0.204437:0.216593:0.010690:0.009578:0.009514:0.009557:0.005345:0.009471:0.009578:0.009578:0.005345:0.009471:0.004276:0.009493:0.005388:0.010690:0.008295:0.009621:0.009706:0.009578:0.004276:0.005345:0.009578:0.004682:0.005430:0.015308:0.008637:0.009578:0.004276:0.008295:0.004276:0.009493:0.008702:0.004682:0.005523:0.011802:0.008274:0.004661:0.004276:0.009578:0.009621:0.008231:0.004276:0.005345:0.011866:0.009557:0.004276:0.008231:0.008766:0.006072:0.008253:0.004276:0.004725:0.008274:0.005388:0.009578:0.004682:0.005259:0.010690:0.004276:0.009557:0.009557:0.008231:0.009578:0.009578:0.006072:0.008766:0.004682:0.005345:0.010690:0.004276:0.009621:0.009557:0.008231:0.009578:0.009578:0.006072:0.008813:0.005345
Correspondence Email: bchtoohp@nus.edu.sg :@0.324734:0.264446:0.680754:0.264446:0.680754:0.246425:0.324734:0.246425:0.011823:0.009578:0.006072:0.006136:0.008702:0.008253:0.009578:0.009578:0.009514:0.009578:0.008766:0.009621:0.008295:0.008637:0.005430:0.009692:0.014367:0.008274:0.004276:0.004276:0.004682:0.005409:0.009578:0.008295:0.009493:0.004661:0.009578:0.009578:0.009535:0.009578:0.017082:0.009664:0.009599:0.008253:0.004682:0.008680:0.009578:0.009514:0.004682:0.008253:0.009854:0.005345
 :@0.655597:0.503436:0.662848:0.503436:0.662848:0.482872:0.655597:0.482872:0.007251
Early cancer detection significantly improves survival rates and quality of life. However, :@0.171085:0.539784:0.920038:0.539784:0.920038:0.519721:0.171085:0.519721:0.010664:0.009164:0.006689:0.004761:0.009212:0.007807:0.009236:0.009164:0.010711:0.009236:0.009688:0.006760:0.007760:0.010664:0.009759:0.005094:0.009759:0.009236:0.005094:0.004761:0.010664:0.010711:0.007760:0.009236:0.004761:0.010640:0.010711:0.004665:0.005213:0.004761:0.009236:0.009164:0.010711:0.004951:0.004761:0.009212:0.007807:0.004761:0.015900:0.010664:0.006760:0.010664:0.009164:0.009640:0.009236:0.007807:0.009236:0.010687:0.006760:0.008926:0.004761:0.009069:0.009164:0.004665:0.007807:0.006760:0.009164:0.005189:0.009664:0.009236:0.007807:0.009164:0.010711:0.010664:0.007783:0.010664:0.010687:0.009164:0.004761:0.004642:0.005189:0.009212:0.007807:0.010664:0.005284:0.007807:0.004761:0.004642:0.005213:0.009759:0.005213:0.007879:0.013139:0.010664:0.013258:0.009759:0.009045:0.009759:0.006641:0.005403:0.005951
about  50%  of  cancers  are  still  diagnosed  at  advanced  stages.  Innovations  in  early  detection, :@0.085519:0.563166:0.920043:0.563166:0.920043:0.543104:0.085519:0.543104:0.009164:0.010664:0.010664:0.010687:0.005189:0.005951:0.004951:0.010545:0.010664:0.016828:0.005951:0.004880:0.010664:0.005213:0.005951:0.004951:0.009117:0.009164:0.010711:0.009236:0.009664:0.006760:0.009188:0.005951:0.005022:0.009164:0.006665:0.009759:0.005951:0.004927:0.009236:0.005189:0.004642:0.004761:0.004642:0.005951:0.004856:0.010664:0.004761:0.009093:0.010640:0.010711:0.010664:0.009307:0.009759:0.010473:0.005951:0.004999:0.009164:0.005094:0.005951:0.004999:0.009164:0.010497:0.009164:0.009069:0.010711:0.009236:0.009759:0.010664:0.005951:0.004975:0.009236:0.005189:0.009069:0.010640:0.009759:0.009117:0.005141:0.005951:0.004999:0.005332:0.010640:0.010711:0.010664:0.009164:0.009093:0.005189:0.004642:0.010664:0.010711:0.009236:0.005951:0.004999:0.004761:0.010640:0.005951:0.004999:0.009545:0.009164:0.006665:0.004761:0.009212:0.005951:0.004999:0.010664:0.009759:0.005094:0.009759:0.009236:0.005094:0.004761:0.010664:0.010711:0.005213:0.005951
especially  liquid  biopsies,  are  promising  due  to  their  potential  to  provide  insights  on  disease :@0.085519:0.586549:0.920366:0.586549:0.920366:0.566486:0.085519:0.566486:0.009759:0.009188:0.010664:0.009759:0.009236:0.004761:0.009069:0.004761:0.004642:0.009212:0.005951:0.004618:0.004761:0.004642:0.010664:0.010687:0.004761:0.010664:0.005951:0.004570:0.010664:0.004761:0.010664:0.010545:0.009236:0.004761:0.009640:0.009188:0.005213:0.005951:0.004570:0.009164:0.006665:0.009759:0.005951:0.004356:0.010545:0.006760:0.010664:0.015995:0.004642:0.009236:0.004761:0.010640:0.010640:0.005951:0.004475:0.010664:0.010687:0.009759:0.005951:0.004546:0.005189:0.010497:0.005951:0.004570:0.005189:0.010640:0.009759:0.004642:0.006760:0.005951:0.004523:0.010664:0.010664:0.005189:0.009688:0.010711:0.005118:0.004761:0.009069:0.004761:0.005951:0.004523:0.005260:0.010664:0.005951:0.004594:0.010664:0.006760:0.010664:0.009463:0.004761:0.010664:0.009521:0.005951:0.004570:0.004761:0.010640:0.009236:0.004761:0.010640:0.010545:0.005189:0.009188:0.005951:0.004594:0.010664:0.010568:0.005951:0.004570:0.010664:0.004594:0.009236:0.009759:0.009045:0.009236:0.009545:0.005951
prognosis, progression, and therapy responses in less invasive ways. Developing these innovations :@0.085519:0.609931:0.920424:0.609931:0.920424:0.589868:0.085519:0.589868:0.010664:0.006760:0.010664:0.010640:0.010711:0.010568:0.009236:0.004761:0.009069:0.005213:0.005951:0.010664:0.006546:0.010664:0.010687:0.006546:0.009759:0.009188:0.009259:0.004761:0.010664:0.010521:0.005213:0.005951:0.009069:0.010711:0.010664:0.005855:0.005189:0.010640:0.009759:0.006641:0.009164:0.010664:0.009212:0.005951:0.006641:0.009759:0.009188:0.010568:0.010664:0.010568:0.009236:0.009759:0.009188:0.005855:0.004761:0.010640:0.005855:0.004570:0.009759:0.009188:0.009259:0.005855:0.004761:0.010640:0.009164:0.009069:0.009236:0.004761:0.009069:0.009759:0.005784:0.013377:0.009164:0.009093:0.009236:0.005213:0.005760:0.013115:0.009759:0.009045:0.009759:0.004642:0.010664:0.010664:0.004761:0.010711:0.010640:0.005879:0.005189:0.010640:0.009759:0.009188:0.009759:0.005784:0.004761:0.010640:0.010711:0.010664:0.009164:0.009093:0.005189:0.004642:0.010664:0.010711:0.009188:0.005951
involves translating fundamental science into practical diagnostic or surveillance tools, a process :@0.085519:0.633314:0.920067:0.633314:0.920067:0.613251:0.085519:0.613251:0.004761:0.010640:0.009164:0.010664:0.004689:0.009164:0.009640:0.009236:0.008236:0.005189:0.006641:0.009164:0.010711:0.009188:0.004761:0.009069:0.005189:0.004761:0.010711:0.010640:0.008164:0.005213:0.010687:0.010711:0.010664:0.009164:0.015995:0.009688:0.010711:0.005118:0.009164:0.004665:0.008093:0.009236:0.009236:0.004761:0.009664:0.010711:0.009236:0.009759:0.008188:0.004761:0.010640:0.005189:0.010497:0.008236:0.010664:0.006760:0.009093:0.009117:0.005189:0.004642:0.009236:0.009164:0.004761:0.008164:0.010664:0.004761:0.009093:0.010640:0.010711:0.010664:0.009307:0.005189:0.004642:0.009117:0.008236:0.010545:0.006760:0.008188:0.009236:0.010687:0.006760:0.009069:0.009759:0.004642:0.004761:0.004642:0.009164:0.010711:0.009236:0.009664:0.008236:0.005189:0.010664:0.010664:0.004761:0.009188:0.005213:0.008164:0.008974:0.008236:0.010664:0.006760:0.010664:0.009236:0.009569:0.009236:0.009188:0.005951
fraught with regulatory and commercial challenges. Over the years, we have navigated and continued :@0.085519:0.656696:0.920477:0.656696:0.920477:0.636633:0.085519:0.636633:0.005213:0.006760:0.009164:0.010687:0.010640:0.010711:0.005189:0.005070:0.013377:0.004761:0.005094:0.010711:0.005118:0.006760:0.009640:0.010640:0.010687:0.004618:0.009164:0.005094:0.010664:0.006760:0.009212:0.005141:0.009164:0.010711:0.010664:0.005094:0.009117:0.010664:0.015995:0.015995:0.009664:0.006718:0.009236:0.004761:0.009164:0.004642:0.005141:0.009236:0.010711:0.009164:0.004665:0.004761:0.009640:0.010711:0.010640:0.009759:0.009188:0.005284:0.004999:0.013139:0.009164:0.009616:0.006760:0.005070:0.005189:0.010640:0.009759:0.005070:0.009212:0.009759:0.009164:0.006641:0.009236:0.005213:0.005189:0.013258:0.009759:0.005070:0.010711:0.009164:0.009069:0.009759:0.005070:0.010711:0.009164:0.009069:0.004761:0.010640:0.009164:0.005094:0.009759:0.010664:0.005094:0.009164:0.010711:0.010664:0.005094:0.009236:0.010664:0.010711:0.005189:0.004689:0.010711:0.010687:0.009664:0.010664:0.005951
on  this  path,  facing  numerous  obstacles  in  bringing  laboratory  discoveries  to  patient  use.  Our :@0.085519:0.680011:0.920019:0.680011:0.920019:0.659948:0.085519:0.659948:0.010664:0.010711:0.005951:0.003856:0.005189:0.010640:0.004761:0.009188:0.005951:0.003880:0.010664:0.009164:0.005118:0.010711:0.005213:0.005951:0.003761:0.005213:0.009164:0.009140:0.004761:0.010640:0.010640:0.005951:0.003904:0.010711:0.010687:0.015995:0.009640:0.006760:0.010664:0.010687:0.009188:0.005951:0.003761:0.010545:0.010664:0.009259:0.005189:0.009069:0.009236:0.004761:0.009664:0.009236:0.005951:0.003856:0.004761:0.010640:0.005951:0.003856:0.010664:0.006760:0.004665:0.010711:0.010521:0.004761:0.010640:0.010640:0.005951:0.003904:0.004761:0.009069:0.010664:0.010664:0.006760:0.009164:0.005070:0.010664:0.006760:0.009212:0.005951:0.003880:0.010664:0.004761:0.009188:0.009283:0.010664:0.009164:0.009688:0.006760:0.004642:0.009759:0.009188:0.005951:0.003880:0.005189:0.010664:0.005951:0.003832:0.010664:0.009164:0.005118:0.004761:0.009640:0.010711:0.005118:0.005951:0.003856:0.010687:0.009236:0.009759:0.005213:0.005951:0.003856:0.013139:0.010687:0.006522:0.005951
journey, driven by curiosity and supported by private funding, led to the creation of the Singapore-:@0.085519:0.703393:0.914450:0.703393:0.914450:0.683331:0.085519:0.683331:0.004975:0.010664:0.010687:0.006760:0.010711:0.009664:0.009212:0.005308:0.006236:0.010664:0.006760:0.004665:0.009164:0.009640:0.010711:0.006236:0.010545:0.009212:0.006308:0.009236:0.010687:0.006760:0.004665:0.010664:0.009259:0.004761:0.005070:0.009212:0.006308:0.009164:0.010711:0.010664:0.006070:0.009188:0.010687:0.010664:0.010664:0.010664:0.006760:0.005094:0.009759:0.010664:0.006212:0.010664:0.009259:0.006236:0.010664:0.006760:0.004665:0.008974:0.009164:0.005094:0.009759:0.006189:0.005213:0.010687:0.010711:0.010664:0.004761:0.010711:0.010640:0.005284:0.006236:0.004761:0.009640:0.010664:0.006284:0.005189:0.010664:0.006212:0.005189:0.010640:0.009759:0.006189:0.009236:0.006760:0.009664:0.009164:0.005094:0.004761:0.010664:0.010711:0.006189:0.010664:0.005284:0.006236:0.005189:0.010640:0.009759:0.006189:0.011901:0.004761:0.010711:0.010640:0.009164:0.011289:0.010664:0.006760:0.009657:0.007950
based startup, MiRXES. This narrative aims to inspire those considering a transition from academia, :@0.085519:0.726776:0.920328:0.726776:0.920328:0.706713:0.085519:0.706713:0.010664:0.009164:0.009188:0.009759:0.010664:0.005713:0.009236:0.005189:0.009069:0.006760:0.005070:0.010687:0.010664:0.005284:0.005855:0.017043:0.004618:0.012163:0.011901:0.010568:0.011901:0.005332:0.005713:0.010640:0.010711:0.004761:0.009188:0.005951:0.010640:0.009164:0.006665:0.006760:0.009069:0.005189:0.004642:0.009164:0.009640:0.005855:0.009164:0.004761:0.015995:0.009259:0.005855:0.005189:0.010664:0.005808:0.004761:0.010640:0.009236:0.010664:0.004594:0.006760:0.009640:0.005855:0.005189:0.010640:0.010664:0.009259:0.009759:0.005784:0.009236:0.010664:0.010592:0.009236:0.004761:0.010664:0.009664:0.006760:0.004642:0.010711:0.010640:0.005879:0.009164:0.005808:0.005189:0.006641:0.009164:0.010711:0.009188:0.004761:0.005094:0.004761:0.010664:0.010711:0.005784:0.005213:0.006760:0.010664:0.015995:0.005832:0.009164:0.009236:0.009164:0.010664:0.009664:0.015995:0.004665:0.009164:0.005213:0.005951
demonstrating how a commitment to a meaningful vision can lead to a fulfilling and successful :@0.085519:0.750158:0.920090:0.750158:0.920090:0.730095:0.085519:0.730095:0.010664:0.009759:0.015924:0.010664:0.010711:0.009236:0.005189:0.006641:0.009164:0.005094:0.004761:0.010640:0.010640:0.008998:0.010545:0.010664:0.013377:0.008998:0.008974:0.008950:0.009236:0.010664:0.015995:0.015995:0.004761:0.005070:0.015995:0.009664:0.010711:0.005118:0.008950:0.005189:0.010664:0.008926:0.009164:0.008902:0.015995:0.009664:0.009164:0.010711:0.004642:0.010711:0.010521:0.005141:0.010687:0.004761:0.008902:0.009164:0.004665:0.009236:0.004761:0.010664:0.010711:0.008760:0.009236:0.009164:0.010711:0.008926:0.004761:0.009640:0.009164:0.010664:0.008950:0.005189:0.010497:0.008950:0.009164:0.008760:0.005213:0.010687:0.004761:0.005213:0.004761:0.004761:0.004665:0.004761:0.010640:0.010640:0.008855:0.009164:0.010711:0.010664:0.008926:0.009188:0.010687:0.009236:0.009236:0.009545:0.009236:0.009188:0.005213:0.010687:0.004761:0.005951
venture.:@0.085519:0.773541:0.152452:0.773541:0.152452:0.753478:0.085519:0.753478:0.009164:0.009640:0.010711:0.005118:0.010687:0.006760:0.009640:0.005213
 :@0.152651:0.775657:0.163231:0.775657:0.163231:0.745653:0.152651:0.745653:0.010580
 :@0.494774:0.775657:0.504288:0.775657:0.504288:0.743581:0.494774:0.743581:0.009514